newsfilter
← Latest News
ACCESS Newswire·

Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process

JACKSON CENTER, PA / ACCESSWIRE / June 21, 2021 / Halberd Corporation's (OTC:HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating the antibody-disease combination through radiofrequency wa